PMID: 9543213Jul 21, 1998Paper

Minor depressive disorder and subsyndromal depressive symptoms: functional impairment and response to treatment

Journal of Affective Disorders
M H Rapaport, L L Judd

Abstract

This study quantifies functional impairment and depressive symptomatology in patients with minor depressive disorder (MinD) and subsyndromal depressive symptomatology (SSD) before and after 8 weeks of treatment with fluvoxamine. Study patients were compared and contrasted with archival data from a sample of the general population measured by the Medical Outcome Survey Short Form 36. Fifteen patients with MinD and 15 patients with SSD were identified from primary care clinics, referrals and newspaper advertisements. Patients signed informed consent and were offered open label treatment with fluvoxamine 25-100 mg/day. Patients were seen biweekly and measures of functional impairment and depressive symptomatology were gathered systematically. MinD and SSD were associated with dysfunction and disability when compared to archival normative data from the general population. Eight week treatment with fluvoxamine was associated with a substantial decrease in depressive symptomatology and a normalization of psychosocial functioning. This is the first study to quantify functional impairment and the severity of depressive symptomatology in a clinical sample of patients with MinD and SSD, and to demonstrate that treatment with a selective ...Continue Reading

References

May 1, 1986·Psychiatry Research·A J RushC Burns
Oct 1, 1993·Health Economics·R D HaysR M Mazel
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON

❮ Previous
Next ❯

Citations

Apr 13, 2013·European Child & Adolescent Psychiatry·Eszter A Bertha, Judit Balázs
May 24, 2008·Journal of General Internal Medicine·Jennifer T RossDavid W Oslin
Apr 7, 2004·Archives of Gerontology and Geriatrics·Riitta-Liisa Heikkinen, Markku Kauppinen
Feb 13, 2004·Biological Psychiatry·Mary F MorrisonMichelle Battistini
Feb 6, 2004·General Hospital Psychiatry·George I PapakostasMaurizio Fava
Mar 17, 2004·Journal of Affective Disorders·Pim CuijpersSaskia van Dorsselaer
Sep 1, 2000·Journal of Affective Disorders·M D Van den BergJ Ormel
Nov 1, 2003·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Virginia Elderkin-ThompsonRuben E Gur
Sep 27, 2000·European Psychiatry : the Journal of the Association of European Psychiatrists·J BalázsG Ostorharics
May 23, 2012·International Psychogeriatrics·Ma Shwe Zin NyuntTze Pin Ng
Dec 29, 2000·The Australian and New Zealand Journal of Psychiatry·R A Parslow, A F Jorm
May 7, 2002·The Australian and New Zealand Journal of Psychiatry·J Snowdon
Apr 7, 2007·Journal of Psychiatric Practice·Roger S McIntyreSidney H Kennedy
Feb 26, 2009·Journal of Psychiatric Practice·Paul E KeckRuth Ross
Aug 28, 2012·The Journal of Nervous and Mental Disease·Michael T Moore, Timothy A Brown
Oct 15, 2008·Current Opinion in Psychiatry·Kua Ee Heok, Roger Ho
Apr 5, 2011·Psychiatric Services : a Journal of the American Psychiatric Association·John KasckowDavid W Oslin
Sep 10, 2014·International Journal of Cognitive Therapy·Jacqueline HershSara J Becker
Oct 13, 2006·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Annemieke van StratenMarianne Donker
Aug 9, 2002·Journal of Affective Disorders·Arun V RavindranHymie Anisman
May 4, 2010·The British Journal of Psychiatry : the Journal of Mental Science·José L Ayuso-MateosSomnath Chatterji
Jan 5, 2011·The British Journal of Psychiatry : the Journal of Mental Science·Corrado BarbuiMark van Ommeren
Mar 1, 2002·General Hospital Psychiatry·Giuseppe Berti CeroniWayne Katon
Dec 14, 2002·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Michael BauerUNKNOWN World Federation of Societies of Biological Psychiatry (WFSBF) Task Force on Treatment Guidelines for Unipolar Depressive Di
Mar 9, 2010·Prostaglandins, Leukotrienes, and Essential Fatty Acids·O J G SchiepersM P J van Boxtel
Feb 24, 2009·Journal of Affective Disorders·Olga J G SchiepersMartin P J van Boxtel
May 8, 2002·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Helen Lavretsky, Anand Kumar
May 8, 2002·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Thomas E Oxman, Anjana Sengupta
Mar 25, 2008·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Dan J SteinFrancine Mandel
Jun 5, 2007·Journal of Affective Disorders·Viola SpekVictor Pop
Jul 22, 2005·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Gloria González-TejeraJosé Bauermeister
Jun 10, 2009·International Journal of Methods in Psychiatric Research·Ingvar BjellandHelena C Kraemer
May 15, 2007·Acta Psychiatrica Scandinavica·P CuijpersA van Straten
Feb 17, 2007·Acta Psychiatrica Scandinavica·P CuijpersA Beekman
Oct 31, 2009·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Catherine M GalleraniNina C Martin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.